Cytosine arabinoside administered intrathecally in cerebromeningeal leukemia.
D000293:Adolescent; D001927:Brain Diseases / Q000175:diagnosis / Q000188:drug therapy*; D002490:Central Nervous System / Q000503:physiopathology; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004569:Electroencephalography; D006801:Humans; D007278:Injections, Spinal; D007945:Leukemia, Lymphoid / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D003561:Cytarabine; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate